Your browser doesn't support javascript.
Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults.
Solmi, Marco; Thompson, Trevor; Estradé, Andrés; Agorastos, Agorastos; Radua, Joaquim; Cortese, Samuele; Dragioti, Elena; Leisch, Friedrich; Vancampfort, Davy; Thygesen, Lau Caspar; Aschauer, Harald; Schlögelhofer, Monika; Aschauer, Elena; Schneeberger, Andres; Huber, Christian G; Hasler, Gregor; Conus, Philippe; Do Cuénod, Kim Q; von Känel, Roland; Arrondo, Gonzalo; Fusar-Poli, Paolo; Gorwood, Philip; Llorca, Pierre-Michel; Krebs, Marie-Odile; Scanferla, Elisabetta; Kishimoto, Taishiro; Rabbani, Golam; Skonieczna-Zydecka, Karolina; Brambilla, Paolo; Favaro, Angela; Takamiya, Akihiro; Zoccante, Leonardo; Colizzi, Marco; Bourgin, Julie; Kaminski, Karol; Moghadasin, Maryam; Seedat, Soraya; Matthews, Evan; Wells, John; Vassilopoulou, Emilia; Gadelha, Ary; Su, Kuan-Pin; Kwon, Jun Soo; Kim, Minah; Lee, Tae Young; Papsuev, Oleg; Manková, Denisa; Boscutti, Andrea; Gerunda, Cristiano; Saccon, Diego.
  • Solmi M; University of Ottawa, Department of Psychiatry, Ontario, Canada; The Ottawa Hospital, Department of Mental Health, Ontario, Canada; Ottawa Hospital Research Institute (OHRI) Clinical Epidemiology Program, Ottawa, Ontario, Canada; Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Depa
  • Thompson T; Centre for Chronic Illness and Ageing, University of Greenwich, London, United Kingdom. Electronic address: T.Thompson@greenwich.ac.uk.
  • Estradé A; Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology& Neuroscience, King's College London, London, United Kingdom; Universidad Católica, Department of Psychology, Montevideo, Uruguay. Electronic address: andres.est
  • Agorastos A; Aristotle University of Thessaloniki, II. Dept. of Psychiatry, Division of Neurosciences, Medical School, Faculty of Health Sciences, Greece. Electronic address: aagorast@auth.gr.
  • Radua J; Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology& Neuroscience, King's College London, London, United Kingdom; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Imaging of Mood- and Anxiety-Re
  • Cortese S; University of Southampton, Centre for Innovation in Mental Health, Southampton, United Kingdom. Electronic address: samuele.cortese@soton.ac.uk.
  • Dragioti E; Ottawa Hospital Research Institute (OHRI) Clinical Epidemiology Program, Ottawa, Ontario, Canada; University of Ioannina, Research Laboratory Psychology of Patients, Families & Health Professionals, Department of Nursing, School of Health Sciences, Ioannina, Greece. Electronic address: elena.dra
  • Leisch F; University of Natural Resources and Life Sciences, Wien, Austria. Electronic address: Friedrich.Leisch@boku.ac.at.
  • Vancampfort D; Katholieke Universiteit Leuven (KU Leuven), Department of Rehabilitation Sciences, Leuven, Belgium. Electronic address: davy.vancampfort@kuleuven.be.
  • Thygesen LC; National Institute of Public Health, University of Southern Denmark, Denmark. Electronic address: lct@sdu.dk.
  • Aschauer H; BioPsyC - Biopsychosocial Corporation, Non-profit association for Research Funding Ltd., Vienna, Austria. Electronic address: harald.aschauer@biopsyc.at.
  • Schlögelhofer M; BioPsyC - Biopsychosocial Corporation, Non-profit association for Research Funding Ltd., Vienna, Austria. Electronic address: monika.schloegelhofer@biopsyc.at.
  • Aschauer E; BioPsyC - Biopsychosocial Corporation, Non-profit association for Research Funding Ltd., Vienna, Austria. Electronic address: elena.aschauer@biopsyc.at.
  • Schneeberger A; University of California San Diego, California, United States. Electronic address: aschneeberger@health.ucsd.edu.
  • Huber CG; University of Basel, Universitäre Psychiatrische Kliniken Basel (UPK), Basel, Switzerland. Electronic address: christian.huber@unibas.ch.
  • Hasler G; University of Fribourg, Fribourg Network of Mental Health (RFSM), Fribourg, Switzerland. Electronic address: gregor.hasler@unifr.ch.
  • Conus P; University of Lausanne, Department of Psychiatry, Lausanne, Switzerland. Electronic address: philippe.conus@chuv.ch.
  • Do Cuénod KQ; University of Lausanne, Department of Psychiatry, Lausanne, Switzerland. Electronic address: Kim.Do@chuv.ch.
  • von Känel R; University of Zurich, University Hospital Zurich, Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, Switzerland. Electronic address: roland.vonkaenel@usz.ch.
  • Arrondo G; University of Southampton, Centre for Innovation in Mental Health, Southampton, United Kingdom; University of Navarra, Mind-Brain Group, Institute for Culture and Society (ICS), Pamplona, Spain. Electronic address: garrondo@unav.es.
  • Fusar-Poli P; Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology& Neuroscience, King's College London, London, United Kingdom; OASIS service, South London and Maudsley NHS Foundation Trust, London, United Kingdom; University o
  • Gorwood P; Université Paris Cité, CMME, GHU Paris Psychiatrie et Neurosciences, Paris, France; Institute de Psychiatrie et Neuroscience de Paris, INSERM U1266, F-75014 Paris, France. Electronic address: p.gorwood@ghu-paris.fr.
  • Llorca PM; Université Clermont Auvergne, CHU Clermont-Ferrand, Service de Psychiatrie B, Clermont-Ferrand, France. Electronic address: pmllorca@chu-clermontferrand.fr.
  • Krebs MO; Institute de Psychiatrie et Neuroscience de Paris, INSERM U1266, F-75014 Paris, France; Université de Paris, PEPIT, GHU Paris Psychiatrie et Neuroscience, Paris, France. Electronic address: MO.KREBS@ghu-paris.fr.
  • Scanferla E; Université Paris Cité, CMME, GHU Paris Psychiatrie et Neurosciences, Paris, France. Electronic address: e.scanferla@ghu-paris.fr.
  • Kishimoto T; Keio University School of Medicine, Department of Neuropsychiatry, Tokyo, Japan. Electronic address: tkishimoto@keio.jp.
  • Rabbani G; The National Foundation of Mental Health of Bangladesh, Bangladesh.
  • Skonieczna-Zydecka K; Pomeranian Medical University in Szczecin, Department of Biochemical Sciences, Szczecin, Poland. Electronic address: karzyd@pum.edu.pl.
  • Brambilla P; University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Department of Neurosciences and Mental Health, Milan, Italy. Electronic address: paolo.brambilla1@unimi.it.
  • Favaro A; University of Padua, Neurosciences Department, Padua, Italy. Electronic address: angela.favaro@unipd.it.
  • Takamiya A; Keio University School of Medicine, Department of Neuropsychiatry, Tokyo, Japan. Electronic address: akihiro.takamiya@keio.jp.
  • Zoccante L; Integrated University Hospital of Verona, Child and Adolescent Neuropsychiatry Unit, Maternal-Child Integrated Care Department, Verona, Italy. Electronic address: leonardo.zoccante@aovr.veneto.it.
  • Colizzi M; University of Udine, Department of Medicine (DAME), Unit of Psychiatry, Italy. Electronic address: marco.colizzi@uniud.it.
  • Bourgin J; Service de Psychiatrie de l'enfant et de l'adolescent, GHNE, 91440, Bures Sur Yvette, France. Electronic address: j.bourgin@gh-nord-essonne.fr.
  • Kaminski K; Medical University of Bialystok, Department of Population Medicine and Lifestyle Diseases Prevention, Bialystok, Poland. Electronic address: fizklin@gmail.com.
  • Moghadasin M; Kharazmi University, Department of Clinical Psychology, Faculty of Psychology and Education, Tehran, Iran. Electronic address: mmoghadasin@yahoo.com.
  • Seedat S; South African Medical Research Council Unit on the Genomics of Brain Disorders, Stellenbosch University, Department of Psychiatry, Faculty of Medicine and Health Sciences, South Africa. Electronic address: sseedat@sun.ac.za.
  • Matthews E; South East Technological University, School of Health Science, Waterford, Ireland. Electronic address: ematthews@wit.ie.
  • Wells J; South East Technological University, School of Health Science, Waterford, Ireland. Electronic address: jswells@wit.ie.
  • Vassilopoulou E; University of Nicosia, Department of Life and Health Sciences, Nicosia, Cyprus. Electronic address: vassilopoulouemilia@gmail.com.
  • Gadelha A; Universidade Federal de São Paulo, Department of Psychiatry, São Paulo, Brazil. Electronic address: aryararipe@gmail.com.
  • Su KP; An-Nan Hospital, China Medical University, Department of Psychiatry, Tainan, Taiwan; China Medical University Hospital, Mind-Body Interface Research Center, Taichung, Taiwan. Electronic address: cobol@cmu.edu.tw.
  • Kwon JS; Seoul National University College of Medicine, Department of Psychiatry, Seoul, Republic of Korea. Electronic address: kwonjs@snu.ac.kr.
  • Kim M; Seoul National University Hospital, Department of Neuropsychiatry, Seoul, Republic of Korea. Electronic address: verte82@snu.ac.kr.
  • Lee TY; Pusan National University Yangsan Hospital, Department of Psychiatry, Yangsan, Republic of Korea. Electronic address: leetaey@gmail.com.
  • Papsuev O; Moscow Research Institute of Psychiatry, Moscow, Russia. Electronic address: oleg.papsouev@gmail.com.
  • Manková D; National Institute of Mental Health, Klecany, Czech Republic. Electronic address: denisa.mankova@nudz.cz.
  • Boscutti A; University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy. Electronic address: a.boscutti@gmail.com.
  • Gerunda C; University of Padua, Neurosciences Department, Padua, Italy. Electronic address: cristiano.gerunda@unipd.it.
  • Saccon D; AULSS4 Veneto Orientale, Addictions Department, Italy. Electronic address: diego.saccon@aulss4.veneto.it.
J Affect Disord ; 326: 249-261, 2023 04 01.
Article in English | MEDLINE | ID: covidwho-2245357
ABSTRACT

BACKGROUND:

The Collaborative Outcome study on Health and Functioning during Infection Times (COH-FIT; www.coh-fit.com) is an anonymous and global online survey measuring health and functioning during the COVID-19 pandemic. The aim of this study was to test concurrently the validity of COH-FIT items and the internal validity of the co-primary outcome, a composite psychopathology "P-score".

METHODS:

The COH-FIT survey has been translated into 30 languages (two blind forward-translations, consensus, one independent English back-translation, final harmonization). To measure mental health, 1-4 items ("COH-FIT items") were extracted from validated questionnaires (e.g. Patient Health Questionnaire 9). COH-FIT items measured anxiety, depressive, post-traumatic, obsessive-compulsive, bipolar and psychotic symptoms, as well as stress, sleep and concentration. COH-FIT Items which correlated r ≥ 0.5 with validated companion questionnaires, were initially retained. A P-score factor structure was then identified from these items using exploratory factor analysis (EFA) and confirmatory factor analyses (CFA) on data split into training and validation sets. Consistency of results across languages, gender and age was assessed.

RESULTS:

From >150,000 adult responses by May 6th, 2022, a subset of 22,456 completed both COH-FIT items and validated questionnaires. Concurrent validity was consistently demonstrated across different languages for COH-FIT items. CFA confirmed EFA results of five first-order factors (anxiety, depression, post-traumatic, psychotic, psychophysiologic symptoms) and revealed a single second-order factor P-score, with high internal reliability (ω = 0.95). Factor structure was consistent across age and sex.

CONCLUSIONS:

COH-FIT is a valid instrument to globally measure mental health during infection times. The P-score is a valid measure of multidimensional mental health.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Humans Language: English Journal: J Affect Disord Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Humans Language: English Journal: J Affect Disord Year: 2023 Document Type: Article